[HTML][HTML] Diagnosis and treatment of “chronic Lyme”: primum non nocere

P Sébastien, D Jacques, P Catherine, G Xavier - BMC Infectious Diseases, 2023 - Springer
Background Approximately 10% of patients experience prolonged symptoms after Lyme
disease. PTLDS (post treatment Lyme disease syndrome) is a controversial topic. It has …

[HTML][HTML] Spatial and temporal comparison of perceived risks and confirmed cases of Lyme disease: An exploratory study of Google trends

D Kim, S Maxwell, Q Le - Frontiers in Public Health, 2020 - frontiersin.org
Non-specific symptoms in later stages of Lyme disease (LD) may mimic a variety of
autoimmune, viral, or complex diseases. Patients lacking erythema migrans or who test …

[HTML][HTML] A multiple streams approach to understanding the issues and challenges of Lyme disease management in Canada's maritime provinces

M Levesque, M Klohn - … Journal of Environmental Research and Public …, 2019 - mdpi.com
This study examines potential challenges facing Lyme disease patients in Canada's
Maritime provinces—New Brunswick, Nova Scotia, Prince Edward Island—and considers …

[HTML][HTML] Lyme disease: How reliable are serologic results?

D Gregson, G Evans, D Patrick, W Bowie - CMAJ, 2015 - Can Med Assoc
1194 CMAJ, November 3, 2015, 187 (16) quence, patients and physicians should be
cautious in choosing a referral laboratory in the US when seeking “second opinion” serology …

The Spatial and Molecular Epidemiology of Lyme Disease in Eastern Ontario

AM Slatculescu - 2023 - ruor.uottawa.ca
Lyme disease is an emerging tick-borne illness in Canada, with human case numbers
increasing 15-to 20-fold since Lyme disease became nationally notifiable in 2009 until the …

Diagnosis and treatment of" chronic Lyme": primum non nocere. A review

S Prat, J Dalbin, C Plotton, X Gocko - 2023 - researchsquare.com
BACKGROUND: Approximately 10% of patients experience prolonged symptoms after Lyme
disease. PTLDS (post treatment Lyme disease syndrome) is a controversial topic. It has …